Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
In This Article:
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.
While you may have an investing style you rely on, finding great stocks is made easier with the Zacks Style Scores. These are complementary indicators that rate stocks based on value, growth, and/or momentum characteristics.
Why Investors Should Pay Attention to This Value Stock
Value investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks.
Conmed (CNMD)
Headquartered in Utica, N.Y., CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. CONMED has roughly 3,600 employees and several manufacturing facilities.
CNMD is a Zacks Rank #3 (Hold) stock, with a Value Style Score of A and VGM Score of A. Shares are currently trading at a forward P/E of 15.6X for the current fiscal year compared to the Medical - Dental Supplies industry's P/E of 16.8X. Additionally, CNMD has a PEG Ratio of 0.8 and a Price/Cash Flow ratio of 10.3X. Value investors should also note CNMD's Price/Sales ratio of 1.5X.
A company's earnings performance is important for value investors as well. For fiscal 2024, one analyst revised their earnings estimate higher in the last 60 days for CNMD, while the Zacks Consensus Estimate has increased $0.00 to $3.99 per share. CNMD also holds an average earnings surprise of 4.3%.
Investors should take the time to consider CNMD for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CONMED Corporation (CNMD) : Free Stock Analysis Report